Caplight Logo









ViAqua Therapeutics

ViAqua Therapeutics

Private
HaifaHealthcare & Life Scienceshttps://www.viaqua-t.com/

Last Round

VC Round

Sep 5, 2023

Company Overview

ViAqua Therapeutics is a biotechnology company that has developed an orally administered RNA-particle platform to improve disease resistance in aquaculture.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Usage-Based SaaS

AI Layer

Non-AI

Keywords

RNA interferenceoral RNA deliveryRNAishrimp feed supplementaquaculture healthWhite Spot Shrimp VirusWSSVaquaculture biotechnologyshrimp farmingfunctional feedaqua techaquatic animal healthnon-GMO supplementaquaculture disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ViAqua Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ViAqua Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 5, 2023
VC RoundJun 9, 2021
VC RoundJul 5, 2018
AcceleratorSep 1, 2016
View all Funding Rounds

Key People

Founding team and executive leadership

Shai Ufaz

Co-Founder And CEO

Founding Team

ViAqua Therapeutics Investors

Notable investors and investment history

InvestorRounds
TechnionAccelerator, VC Round
S2G InvestmentsVC Round
Rabo VenturesVC Round
Clay CapitalVC Round
The Trendlines GroupVC Round, Accelerator
Clay CapitalVC Round
View all Investors

ViAqua Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ViAqua Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ViAqua Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersHaifa
Employee Range14
Year Founded2014
Last FundingSep 5, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.